Yes very positive presentation I personally think they know the following . 1.The company gets quarterly updates from Acadia and stated that the trofinetide trials are tracking well. 2..The phase 1 trial readout for NNZ2591 is in January you would think they would have a very good indication on how the trial is tracking .
NEU Price at posting:
$1.34 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)